INCYTE CORPORATION Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount
INCYTE CORPORATION (INCY) reported Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount of 10.11 million shares for the 12-month period ending 2021-12-31, per its 10-K filed 2022-02-08.
Discontinued › Income Statement › Earnings Per Share
us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount · last filed 2022-02-08
- INCYTE CORPORATION antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2021-09-30 was 11.84M shares, a 24.47% decline year-over-year.
- INCYTE CORPORATION antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2021-06-30 was 9.24M shares, a 73.11% increase year-over-year.
- INCYTE CORPORATION antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2021-03-31 was 8.87M shares, a 44.25% decline year-over-year.
- INCYTE CORPORATION antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2020-09-30 was 15.68M shares, a 69.27% increase year-over-year.
- INCYTE CORPORATION antidilutive securities excluded from computation of earnings per share, amount for fiscal 2021 was 10.11M shares, a 33.83% decline from fiscal 2020.
- INCYTE CORPORATION antidilutive securities excluded from computation of earnings per share, amount for fiscal 2020 was 15.27M shares, a 57.17% increase from fiscal 2019.
- INCYTE CORPORATION antidilutive securities excluded from computation of earnings per share, amount for fiscal 2019 was 9.72M shares, a 12.68% increase from fiscal 2018.
- INCYTE CORPORATION antidilutive securities excluded from computation of earnings per share, amount for fiscal 2018 was 8.62M shares, a 34.18% decline from fiscal 2017.
| Period end | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month |
|---|---|---|---|---|
| 2021-12-31 | 10.11M shares 10-K · filed 2022-02-08 | |||
| 2021-09-30 | 11.84M shares 10-Q · filed 2021-11-02 | 9.92M shares 10-Q · filed 2021-11-02 | ||
| 2021-06-30 | 9.24M shares 10-Q · filed 2021-08-03 | 8.98M shares 10-Q · filed 2021-08-03 | ||
| 2021-03-31 | 8.87M shares 10-Q · filed 2021-05-04 | |||
| 2020-12-31 | 15.27M shares 10-K · filed 2022-02-08 | |||
| 2020-09-30 | 15.68M shares 10-Q · filed 2021-11-02 | 15.68M shares 10-Q · filed 2021-11-02 | ||
| 2020-06-30 | 5.34M shares 10-Q · filed 2021-08-03 | 14.96M shares 10-Q · filed 2021-08-03 | ||
| 2020-03-31 | 15.91M shares 10-Q · filed 2021-05-04 | |||
| 2019-12-31 | 9.72M shares 10-K · filed 2022-02-08 | |||
| 2019-09-30 | 9.26M shares 10-Q · filed 2020-11-05 | 9.83M shares 10-Q · filed 2020-11-05 | ||
| 2019-06-30 | 9.53M shares 10-Q · filed 2020-08-04 | 9.59M shares 10-Q · filed 2020-08-04 | ||
| 2019-03-31 | 9.69M shares 10-Q · filed 2020-05-05 | |||
| 2018-12-31 | 8.62M shares 10-K · filed 2021-02-09 | |||
| 2018-09-30 | 9.57M shares 10-Q · filed 2019-10-29 | 7.77M shares 10-Q · filed 2019-10-29 | ||
| 2018-06-30 | 8.60M shares 10-Q · filed 2019-07-30 | 7.25M shares 10-Q · filed 2019-07-30 | ||
| 2018-03-31 | 13.62M shares 10-Q · filed 2019-04-30 | |||
| 2017-12-31 | 13.10M shares 10-K · filed 2020-02-13 | |||
| 2017-09-30 | 2.92M shares 10-Q · filed 2018-10-30 | 13.17M shares 10-Q · filed 2018-10-30 | ||
| 2017-06-30 | 12.60M shares 10-Q · filed 2018-07-31 | 12.60M shares 10-Q · filed 2018-07-31 | ||
| 2017-03-31 | 13.51M shares 10-Q · filed 2018-05-01 | |||
| 2016-12-31 | 17.28M shares 10-K · filed 2019-02-14 | |||
| 2016-09-30 | 17.61M shares 10-Q · filed 2017-10-31 | 17.43M shares 10-Q · filed 2017-10-31 | ||
| 2016-06-30 | 17.28M shares 10-Q · filed 2017-08-01 | 17.23M shares 10-Q · filed 2017-08-01 | ||
| 2016-03-31 | 17.14M shares 10-Q · filed 2017-05-04 | |||
| 2015-12-31 | 14.98M shares 10-K · filed 2018-02-15 | |||
| 2015-09-30 | 27.01M shares 10-Q · filed 2016-11-01 | 27.01M shares 10-Q · filed 2016-11-01 | ||
| 2015-06-30 | 19.62M shares 10-Q · filed 2016-08-09 | 32.74M shares 10-Q · filed 2016-08-09 | ||
| 2015-03-31 | 39.47M shares 10-Q · filed 2016-05-09 | |||
| 2014-12-31 | 40.30M shares 10-K · filed 2017-02-14 | |||
| 2014-09-30 | 16.77M shares 10-Q · filed 2015-11-03 | 42.23M shares 10-Q · filed 2015-11-03 | ||
| 2014-06-30 | 42.62M shares 10-Q · filed 2015-08-04 | 42.62M shares 10-Q · filed 2015-08-04 | ||
| 2014-03-31 | 42.96M shares 10-Q · filed 2015-04-30 | |||
| 2013-12-31 | 45.62M shares 10-K · filed 2016-02-12 | |||
| 2013-09-30 | 46.02M shares 10-Q · filed 2014-10-30 | 46.02M shares 10-Q · filed 2014-10-30 | ||
| 2013-06-30 | 53.93M shares 10-Q · filed 2013-08-01 | 53.93M shares 10-Q · filed 2013-08-01 | ||
| 2013-03-31 | 70.82M shares 10-Q · filed 2014-05-01 | |||
| 2012-12-31 | 68.43M shares 10-K · filed 2015-02-17 | |||
| 2012-09-30 | 70.24M shares 10-Q · filed 2013-10-31 | |||
| 2012-06-30 | 53.27M shares 10-Q · filed 2013-08-01 | 71.35M shares 10-Q · filed 2013-08-01 | ||
| 2012-03-31 | 72.80M shares 10-Q · filed 2013-05-02 | |||
| 2011-12-31 | 70.07M shares 10-K · filed 2014-02-21 | |||
| 2011-09-30 | 70.63M shares 10-Q · filed 2012-11-01 | |||
| 2011-06-30 | 70.30M shares 10-Q · filed 2012-08-03 | 70.30M shares 10-Q · filed 2012-08-03 | ||
| 2011-03-31 | 71.36M shares 10-Q · filed 2012-04-26 | |||
| 2010-12-31 | 68.18M shares 10-K · filed 2013-02-21 | |||
| 2010-09-30 | 68.45M shares 10-Q · filed 2011-10-27 | |||
| 2010-06-30 | 49.61M shares 10-Q · filed 2011-07-28 | 68.78M shares 10-Q · filed 2011-07-28 | ||
| 2009-12-31 | 81.65M shares 10-K · filed 2012-02-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| IQVIA HOLDINGS INC. (IQV) | United States | $45.926B | 20.54 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B |